[VRPX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[VRPX] Virpax Pharmaceuticals, Inc.
Announcement Date
07-Dec-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -92.55%
YoY- 20.81%
Quarter Report
VRPX's Result
VRPX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 0 0 0 0 0 0 -
PBT -2,006 -5,994 -7,642 -3,216 -1,708 -1,032 14.20%
Tax 0 -6 -73 29 -1,662 -32 -
NP -2,006 -5,994 -7,569 -3,216 -1,708 -1,032 14.20%
Tax Rate - - - - - - -
Total Cost 2,006 5,994 7,569 3,216 1,708 1,032 14.20%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -0.43 -5.12 -0.65 -0.53 -0.38 -3.52 -34.29%
EPS Diluted -0.43 -5.12 -0.65 -0.53 -0.38 -3.51 -34.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.